ArticleFrontiers in medicine2026
Neuropsychiatric adverse events of SGLT2 inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system database.
Minghui Yin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.